John S. Montalbano bought $110K of ABCL stock

John S. Montalbano, Dir of AbCellera Biologics Inc. (ABCL), bought 10,000 shares of ABCL stock worth $110K, per an SEC Form 4 filed Aug 18, 2026.

It was an open-market purchase.

The trade was reported on Aug 18, 2026.

ABCL has moved +3.3% since the trade date, from $11.12 to $11.49 (Nov 13, 2026 close).